IL1B and neoplasm: Taken together, the imbalance of IL-1 agonists with IL-1 antagonists and their associated receptors/co-receptors within the GI tract may not be limited to promoting inflammatory processes, but may also be important in tumorigenesis and tumor progression (Figure 4).